A randomized, open-label, crossover, prospective study to investigate utility of a new 24-hour application of transdermal fentanyl patch compared to 72-hour application of transdermal fentanyl patch.
Not Applicable
- Conditions
- Pain
- Registration Number
- JPRN-UMIN000004231
- Lead Sponsor
- Department of Pharmacy, Kitasato Institute Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patient who have hypersensitivity to opioids 2.Patient who have history of opioid abuse 3.Patient who have skin disease (eczema or psoriasis) on the upper arms, flat surface of the upper torso or crural area 4.A body temperature higher than 40 degrees 5.Preganat or nursing patients and patients who may be pregnant 6.After application of fentanyl patch within two days, patient who is treated by opioid receptor antagonists such as pentazocine and buprenorphine or will be treated 7.Surgery in the preceding 7 days or scheduled 8.Patient under 20 years old 9.Patient who have a life expectancy of less than 1 month 10.Patient who judges that the primary physician is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Pain intensity daily 2.Adverse events daily 3.Result of questionnaire investigation about utility of each transdermal fentanyl patch
- Secondary Outcome Measures
Name Time Method